Fred Hutch is a world leader in hematopoietic (blood) stem cell transplantation and its use as a treatment for blood cancers, hematological diseases and other conditions. Worldwide, more than a million patients have turned to transplantation to save their lives. For thousands transplantation is not an option because they don't have a genetically matched donor.
Our work began by pioneering bone marrow transplantation and it continues today in our breakthrough research of cord blood transplantation. Cord blood saves lives, and research in the Delaney Lab is bringing powerful cord blood–based therapies to more people who need a new lifesaving option.
Dr. Colleen Delaney, Director for the Fred Hutch Cord Blood Program, developed a method for multiplying, or expanding, key stem cells in cord blood, with the goal of extending the use of this expanded cord blood product into something that could be ordered up by doctors at a moment’s notice. Her vision is to create a therapy that can become FDA approved and be given to patients around the world.